Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
Behandeling lobulair mammacarcinoom vergt specifieker behandelprotocol
mrt 2017 | Borstkanker